Towa Pharmaceutical Co (JP:4553) has released an update.
Towa Pharmaceutical Co., Ltd. has updated its financial forecasts for the six months ending September 30, 2024, and the fiscal year ending March 31, 2025, maintaining net sales projections while increasing forecasted profits. The revision reflects lower than anticipated outsourced manufacturing costs and higher operating profits, with an awareness of market uncertainties that may impact future performance.
For further insights into JP:4553 stock, check out TipRanks’ Stock Analysis page.
